Biodesix (BDSX) vs MDxHealth SA (MDXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Biodesix (BDSX) has outperformed MDxHealth SA (MDXH) over the past year, gaining 230.7% versus a loss of 87.2%. Biodesix is the larger company by market cap ($270.4 million vs $55.4 million), about 4.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDSX | MDXH |
|---|---|---|
| Share price | $25.63 | $0.5805 |
| Market cap | $270.43M | $55.39M |
| 1-day change | -2.99% | -3.22% |
| YTD return | +276.91% | -83.74% |
| 1-year return | +230.71% | -87.16% |
| 5-year return | -82.91% | — |
| EPS (TTM) | $-3.10 | $-0.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.97 | $5.33 |
| 52-week low | $5.26 | $0.40 |
| Distance from 52-week high | -19.83% | -89.11% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +45.65% | +210.08% |
| Average volume | 100.74K | 5.69M |
| Shares outstanding | 10.55M | 95.42M |
| Employees | 334 | 364 |
| Sector | Health Care | Healthcare |
| Industry | Medical Specialities | Diagnostics & Research |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Biodesix is about 4.9 times larger than MDxHealth SA by market value ($270.43M vs $55.39M).
- BDSX has outperformed MDXH by 317.9 percentage points over the past year.
- The two companies sit in different sectors: Biodesix in Health Care and MDxHealth SA in Healthcare.
About Biodesix
BDSX stock →Biodesix, Inc. operates as a diagnostic solutions company.
Health Care · Medical Specialities · 334 employees
About MDxHealth SA
MDXH stock →MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.
Healthcare · Diagnostics & Research · 364 employees
BDSX vs MDXH FAQ
Which is bigger, Biodesix or MDxHealth SA?
Biodesix (BDSX) is larger, with a market capitalization of $270.43M compared with $55.39M for MDxHealth SA (MDXH).
Which stock has performed better over the past year, BDSX or MDXH?
BDSX returned +230.71% over the past 12 months, compared with -87.16% for MDXH (price return, excluding dividends). Past performance does not predict future results.
Are Biodesix and MDxHealth SA in the same industry?
No. Biodesix is in the Health Care sector, while MDxHealth SA is in Healthcare.